Selective factor Xa inhibitors
US6204268A · kind A · utility
12Cited by
31References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 1998 |
| Grant date | Mar 20, 2001 |
| Priority date | — |
| Expiry date | Apr 13, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.